Abstract Keratocystic odontogenic tumor (KOT) is a benign cystic tumor that affects the jaw bones and may be associated with the nevoid basal cell carcinoma syndrome (NBCCS). Twenty-five cases diagnosed as KOT, including primary and recurrent tumors and those associated with NBCCS, were submitted to immunohistochemical study for analysis of cytokeratins (CKs) 7, 8, 10, 13, 14, 18 and 19. The results showed CK13 immunostained on the intermediate layers and upper cells. CK14 was expressed in all epithelial layers and in those areas where inflammation and subepithelial splits were present; this protein was preserved within the basal cells. CK 18 was expressed mainly in the basal layer, whereas CK19 was expressed mainly on the intermediate and superficial layers. The remaining CKs tested were not immuoreactive. The status of maturation of cytokeratin seems to be altered on KOTs, and this is not distinct when different tumors are compared.
Introduction
Keratocystic odontogenic tumor (KOT) is a benign cystic neoplasm that affects jaw bones, originated from dental lamina (Kolar et al. 2006 ) by disturbance on the PTCH gene (Gomez and Marco 2005; Hardcastle et al. 1999) . It may be related to the nevoid basal cell carcinoma syndrome (NBCCS). It is characterized by multiple KOTs, predisposition to the development of basocellular carcinomas, palmar and plantar pits and ectopic calcifications (Ahn et al. 2004) . Histologically, this tumor is composed of a cystic wall lined by thin, stratified squamous, parakeratinized epithelium, exhibiting palisade-like basal cells. Other features include satellite cysts and subepithelial splits. Inflammatory infiltrate may be also seen (El-Hajj and Anneroth 1996; González-Alva et al. 2008; Kolar et al. 2006; Lam and Chan 2000; Myoung et al. 2001; Meningaud et al. 2006; Ochsenius et al. 2007; Tortorici et al. 2008) .
The cytokeratins (CK) are characteristic proteins from epithelium that belong to the group of the intermediate filaments (FIs) present in the cytoskeleton. There are 20 CKs catalogued, and they are classified as type I (acid, from 9 to 20) and type II (basic or neutral, from 1 to 8). Generally, they are expressed in the epithelium as a pair of proteins (heterodimers), being a basic and an acid protein (Chu and Weiss 2002; Cooper et al. 1985) . These heterodimers are distributed as tetramers within the epithelium forming filamentous structures (Barak et al. 2004 ).
Each epithelial tissue shows a profile of cytokeratins, which are useful to their identification and immunophenotypical characterization (Moll et al. 1982; Moll et al. 2008 ). Therefore, the study of the profile of CKs has become one of the main methods to recognize epithelial tumors, and to characterize a disordered epithelial maturation that might be occurring (Santos et al. 2003) . The expression of these proteins depends on the type of epithelium (simple or stratified), differentiation and development status (Barak et al. 2004 ). In addition, the cellular differentiation determines alterations in the cellular components, such as proteins of cytoskeleton, which explains its influence on the expression of the CKs (Shuler and Shriver 1987) . Thus, the status of maturation of the epithelium may be performed through the analysis of the expression of the cytokeratins.
The aim of our study was to describe and compare the status of epithelial maturation of KOTs, using cytokeratins 7, 8, 10, 13, 14, 18 and 19 in an attempt to distinguish sporadic and recurrent lesions and those associated with NBCCS.
Materials and methods
After Institutional Ethics Committee approval, 25 cases of KOTs were obtained from the Laboratory of Oral Surgical Pathology of School of Dentistry of the Federal University of Bahia. All of tumors were surgically removed, and they were represented by ten primary tumors, ten recurrent ones and five associated with NBCCS. The cases were selected considering previous anatomopathological reports.
All sections stained with hematoxylin and eosin were reassessed by an experienced pathologist using the 2005 World Health Organization criteria.
For immunohistochemical study, 3 lm sections from formalin-fixed, paraffin-embedded tissues of all cases were obtained. To assess the status of maturation, cytokeratins (CKs 7, 8, 10, 13, 14, 18 and 19) were used. The primary monoclonal antibodies, dilution, incubation time, pretreatments, and source used are listed in Table 1 . Briefly, tissue sections were deparaffinized, hydrated in a decreasing ethanol sequence and formalin pigment was removed with 10% ammonium hydroxide in 95% ethanol. For CK 10, prior to incubation with the primary antibody, the sections were treated with 1% tripsine, pH 7, 8, at 37°C for 30 min. The sections were incubated with the primary antibodies at 4°C, overnight in humid chamber. After washing in PBS, the sections were treated with labeled Streptavidin-Biotin System (LSAB, Dako Corporation, Carpinteria, USA). Diaminobenzidine (DAB, Dako, Corporation, Carpinteria, USA) was used as chromogen for 2-5 min at room temperature and counterstained with Harris hematoxylin for 10 s and coverslipped. Salivary gland and nevus were used as positive controls. Omission of the primary antibody was performed for negative control.
The immunohistochemistry was evaluated using criteria adapted from Stoll et al. (2005) , and immunopositive cells were identified as a brown color irrespective of staining intensity. The distribution of the proteins was evaluated particularly on the basal, intermediate and upper, and superficial layers, regarding primary and recurrent tumors and those associated with NBCCS. Satellite cysts were also included.
Results
Twenty-five specimens were included in this study, being 13 men and 12 women with a mean age of 36.6 years (SD ± 12.8). Ten lesions were primary, ten recurrent, and five associated with NBCCS. Histologically, the tumors showed parakeratinized epithelium exhibiting atrophy, superficial corrugation and basal cells arranged in palisade. Some cases showed subepithelial splits and epithelial buds and satellite cysts. In addition, discrete to significant mononuclear inflammatory infiltrate was seen in 14 (56%) lesions. The histopathological features are summarized in Table 2 .
The immunohistochemical assessment showed that the CKs 13 (primary tumors, 7/10; recurrent tumors, 6/10; syndrome tumors, 4/5), 14 (primary tumors, 10/10; recurrent tumors, 10/10; syndrome tumors, 5/5), 18 (primary tumors, 2/10; recurrent tumors, 4/10; syndrome tumors, 1/5) and 19 (primary tumors, 9/10; recurrent tumors, 9/10; syndrome tumors, 5/5) were immunoreactive in mostly cases of KOTs (Fig. 1) . However, CKs 7, 8 and 10 were negative in all samples. The immunohistochemical results are summarized in Table 3 .
Immunostaining for CK13 was observed in 17 (68%) cases, particularly involving intermediate and superficial layers, regardless the subjacent inflammatory process, subepithelial splits or thickness of cystic epithelium. Five from these cases showed immunostaining for this CK in satellite cysts, which was seen on peripheral cells or on keratin layers. A few cases, within the same tumor, immunolabeling of CK 13 was seen as clusters of cells or isolated cells. In those tumors exhibiting epithelial buds, the expression of CK 13 was lost, being most often seen on upper and superficial cells.
KOTs showed CK 14 in all epithelial layers, including areas where inflammation and subepithelial splits were present, although this finding was not evident in two cases of recurrent tumors. In addition, other areas within the same tumor showed loss of marking, preserving the basal layer. A few cases, within the same tumor, showed expression of CK 14 as clusters of cells or isolated cells. On the other hand, from nine cases exhibiting satellite cysts, CK14 was also present, but its expression was variable. In those tumors exhibiting epithelial remnants, this CK was present strongly.
Seven cases (28%) were found to be immunopositive for CK 18, with its expression being observed particularly in the basal layer, corresponding to primary, recurrent tumors and those associated with NBCCS. However, all epithelial layers were stained in three cases, including areas with inflammation.
With respect to CK 19, only one case did not show immunostaining. This protein was particularly immunoreactive in all epithelial layers, accounting for 13 (52%) cases. However, it involved only the intermediate and superficial layers in 10 cases (40%). Only one case showed the basal and intermediate layers positive for CK 19. In those cases exhibiting significant presence of inflammatory infiltrate, all epithelial layers were immunoreactive. This CK was present in nine cases exhibiting satellite cysts, being seen both peripheral cells and keratin layers. 
Discussion
The expression of different cytokeratins depends on the cell differentiation, status of development, and type of epithelium (Chu and Weiss 2002; Moll et al. 1982; Moll et al. 2008) . When the keratinocyte cell migration to upper layers of the epithelium occurs, the cells undergo a maturation process, detectable through altered cytokeratin expression (Hormia et al. 1987) . Therefore, the study focusing on epithelial differentiation of KOT may be performed by immunohistochemistry through the analysis of intermediate filaments.
CK 10 is associated with terminal differentiation and keratinization (Koch and Roop 2004; Moll 1998; Stoll et al. 2005) , and has been detected on the lining of odontogenic cysts including KOTs (Stoll et al. 2005; Silva et al. 2002) . In contrast, our results showed absence of immunostaining for this CK in all analyzed cases. This may be attributable to difficulty in the cell maturation. Despite these results using immunohistochemistry, other authors have issued similar reports. Hormia et al. (1987) , in a study with monoclonal antibodies, found absence of immunostaining for specific keratins for keratinized epithelium (CK 1, 9 and 10/11); according to those authors, this result was caused by a pseudokeratinization of the KOT epithelium. In 2000, August et al. showed that after decompression and cystectomy, KOTs dedifferentiate and lose CK 10. In addition, it is important to state that CK 10 is not a typical intermediate filamentous found in odontogenic epithelium (Crivelini et al. 2003) . CK 13 is present in odontogenic epithelium. It has been related to squamous differentiation, and located on suprabasal layers (Hormia et al. 1987; Meara et al. 2000; Silva et al. 2002; Santos et al. 2003) . This immunolocalization was also observed in this study, but superficial layers and isolated cells were also immunolabeled. Despite the different immunolabellings on different epithelial layers, using the same methodology, Silva et al. (2002) observed the expression of CK 13 on the superficial layers and Meara et al. (2000) observed this protein on upper cells within the intermediate layer with similar staining pattern regarding syndromic patients and non-syndromic ones. In addition, other odontogenic lesions as radicular cysts and denigerous cysts also showed positive staining for this protein (Stoll et al. 2005) . Thus, these findings seem to indicate a complex maturation in KOTs (Fig. 1) . CK 14 is the main intermediate filament observed in the dental lamina, in the reduced enamel epithelium, in almost all cells of the enamel organ, and odontogenic tumors as ameloblastomas (Crivelini et al. 2003) . Our data showed immunolabelling of this protein in all cases, including, especially, basal, intermediate and superficial layers. This immunolocalization was seen in those areas exhibiting subepithelial splits and inflammation, although in some cases this was not seen. Silva et al. (2002) and Vargas et al. (2007) showed that CK14 expression was restricted to basal cells. Although some tumors studied in this series also showed basal cells stained, the immunolabeling was not restricted to basal layer. In addition, Silveira et al. (2006) observed immunolabelling for CK 14 in the adjacent epithelium to oral squamous cell carcinomas, and labelling involving only the basal layer of these epithelia in more distant areas of the tumors. Taken together, these results seem to be controversial, and suggest instability in the structural integrity of the KOT as well as altered epithelial differentiation.
The inflammatory infiltrate may induce modifications in the expression of CKs on the epithelium lining, as shown in lesions of actinic cheilitis (Santos et al. 2003) , periodontopathies (Mackenzie and Gao 1993) , supurative hydranite (Kurzen et al. 1999; Wang et al. 2007 ), inflammated gastrical mucosa (Kurokawa et al. 2002) , erythematous lupus (Gürbüz and Köse 2006) , and this may be due to the production of inflammatory cytokines (Silva et al. 2002) . In this study, this aspect was also evidenced in KOT regarding CK 14.
In contrast to previous authors (Gao et al. 1989; Meara et al. 2000) , our study showed expression of CK 18 in KOT. According to Crivelini et al. 2003, CK 18 is not evident in odontogenic epithelium, however, a few cases of glandular odontogenic cyst have shown the opposite (Pires et al. 2004 ). These distinct results may be attributable to the heterogeneity observed in the altered expression pattern of cytokeratins in KOT. Moreover, CK 8/18 has been found in oral leukoplakia with dysplasia and oral squamous cell carcinoma (Fillies et al. 2007) .
CK 19 is detected in simple epithelium and basal cells present in non keratinized epithelium (Crivelini et al. 2003; Moll et al. 1982; Stoll et al. 2005) . In the present study, the CK19 was strongly expressed in almost 96% of KOTs, affecting mainly suprabasal and intermediate layer cells. The absence of strong expression of CK 19 in basal cells may be due to the fact that stem cells or progenitor cells may not be sufficiently detected by this CK, but enough to maintain the phenotype of odontogenic epithelial differentiation. In addition, a study by Stoll et al. (2005) showed CK 19 in radicular cysts and dentigerous cysts, with a completely absent staining in KOTs. These conflicting findings may be due to the different clones used in both studies, and reflect a heterogeneous pattern of immunolabelling in KOTs. According to Crivelini et al. (2003) , ameloblastomas with areas exhibiting metaplastic squamous cells show expression of CK 19 and 13. Similarly, our study showed that both cytokeratins are present in KOTs, indicating that these lesions share the same origin, as CKs 19 and 13 are components of dental lamina. However, this suggests an altered squamous differentiation. In addition, our results showed that areas exhibiting strong inflammation, showed positivity for CK 19 involving all cystic epithelium, as seen in those cases marked with CK14. This may also be related to the production of interleukins, as previously discussed. It is important to state that CK 19 is detected in the epithelium close to squamous cell carcinomas, suggesting its use as a pivotal biologic agent of malignant progression (Xu et al. 1995; Crivelini et al. 2003; Silveira et al. 2006 ). On the other hand, KOTs show high levels of the protein DNp63, which reflects the presence of immature keratinocytes, with high proliferative capacity (Gurgel et al. 2008) . This aspect has been confirmed by the staining for CK 16 and the protein Ki-67 (Gurgel et al. 2008; Gao et al. 1989; Hormia et al. 1987) .
With respect to CKs 7 and 8, we did not detect immunolabelling of these proteins. These CKs are commonly expressed on simple epithelia (Barak et al. 2004; Moll et al. 1982; Moll et al. 2008 ). Nevertheless, they have been showed in dental organ and odontogenic lesions in variable proportions (García et al. 2009; Hormia et al. 1987; Meara et al. 2000; Matthews et al. 1988; Pires et al. 2004; Stoll et al. 2005) .
The altered profile of CKs expression studied seems to be related to the differentiation and maturation status of the cystic epithelium of the KOTs, and this is not distinct when primary and recurrent tumors, and those associated with SCBNN are compared.
